Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-23 · accession 0001960048-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-29 | 2025-12-23 | PCVX | Cowan Elvia | SVP, Fin | S - Sale | $47.92 | -11.6K | 21.2K | -35% | -$557.0K |
| 2025-12-29 | 2025-12-23 | PCVX | Cowan Elvia | SVP, Fin | G - Gift | $0.00 | -1,000 | 13.5K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-23 | S | D | 6,716 | $47.94 | 14,534 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-23 | S | D | 4,907 | $47.90 | 21,250 | D | — | — | (F1) Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2025-12-23 | G | D | 1,000 | $0.00 | 13,534 | D | — | — | (F2) Reflects the bona-fide gift of the Issuer's common stock to a Charitable Donor Advised Fund. |